SAMIR CHANDRAKANT PATEL - 18 Mar 2025 Form 3 Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Role
Director
Signature
/s/ Andrew Oxtoby, Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
18 Mar 2025
Net transactions value
$0
Form type
3
Filing time
18 Mar 2025, 17:21:53 UTC
Next filing
11 Apr 2025

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney